Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian D Williamson
Determination of Optimal Viral Kinetic Markers for Predicting Antiviral Treatment Effect for the Prevention of Cytomegalovirus (CMV) Disease After Hematopoietic Cell Transplant (HCT) Using Machine Learning and a Novel Non-Parametric Estimation Method
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease After Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Cytomegalovirus (CMV) Pentameric Complex (PC) Neutralizing Antibodies (nAb) From a Randomized, Controlled Trial of CMV-Specific Intravenous Immunoglobulin (IVIG) for the Prevention of Primary CMV Infection After Hematopoietic Cell Transplantation (HCT)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Clinical Utility of Quantitative Cytomegalovirus Viral Load Determination for Predicting Cytomegalovirus Disease in Liver Transplant Recipients1
Transplantation
Transplantation
Management of Cytomegalovirus (CMV) in Hematopoietic Stem Cell Transplant (HSCT)
Journal of Pediatrics & Neonatal Care
Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-seropositive Donor and CMV-seronegative Solid Organ Transplant Recipients
Open Forum Infectious Diseases
Oncology
Neurology
Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Pharmacotherapy
Pharmacology
Real World Experience of Letermovir (LTV) Prophylaxis (Px) for the Prevention of Cytomegalovirus Infection (CMVi) in the Adult CMV Seropositive Recipients (R+) of Allogeneic Hematopoietic Cell Transplantation (HCT) Patients (Pts).
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Use of Valacyclovir for the Treatment of Cytomegalovirus Antigenemia After Hematopoietic Stem Cell Transplantation
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Clinical & Economic Burden of Pre-Emptive Therapy (PET) of Cytomegalovirus (CMV) Infection in Hospitalized Allogeneic Hematopoietic Cell Transplant (Allo-Hct) Recipients: The MD Anderson Cancer Center Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
